Results met efficacy criteria for enrollment expansion and provide support for pelareorep's mechanism of action SAN DIEGO and CALGARY, AB, Oct. 23, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ...
Medtronic has announced that an independent Data Monitoring Committee (DMC) reviewed the initial interim analysis and confirmed that the randomised controlled trial of INFUSE Bone Graft in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback